Antiviral Drug News and Research

RSS

Feline virus, antiviral drug studied to understand drug resistance

Researchers at Ohio State will spend the next two years testing their theories about just how an AIDS-like virus in cats is able to resist the powerful medicines that are thrown against it.

10 Oct 2007

Can liver cirrhosis be partially cured?

The diffusion of hepatitis C virus infection worldwide is astonishing. Liver cirrhosis is present in at least 10-20% of these infected patients, with highly increasing health care and emotional costs.

10 Oct 2007

New peptides inhibit HIV's entry into cells

Based in part on protein structures determined at the National Synchrotron Light Source (NSLS) at the U.S. Department of Energy's Brookhaven National Laboratory, scientists at the University of Utah have developed new peptides that appear to be significantly more effective at blocking HIV's entry into cells than other drugs in their class.

9 Oct 2007

Painless microneedles in patches applied to the skin for drug delivery

Flu vaccine delivered through painless microneedles in patches applied to the skin could soon be an alternative to delivery through hypodermic needles, according to researchers at Emory University and the Georgia Institute of Technology in Atlanta.

4 Oct 2007

Oseltamivir, the active substance in Tamiflu, unchanged through sewage treatment

Swedish researchers have discovered that oseltamivir (Tamiflu); an antiviral drug used to prevent and mitigate influenza infections is not removed or degraded during normal sewage treatment.

3 Oct 2007

New way to fight hepatitis B

One in four people who are chronically infected with hepatitis B will die from its impact if untreated, but a team of researchers at the Stanford University School of Medicine has identified the most cost-effective way of fighting this treacherous infection.

2 Oct 2007

Second pathway behind HIV-associated immune system dysfunction identified

Researchers at the Partners AIDS Research Center at Massachusetts General Hospital (PARC-MGH) may have discovered a second molecular "switch" responsible for turning off the immune system's response against HIV.

1 Oct 2007

microRNAs may be key to HIV's ability to hide, evade drugs

Tiny pieces of genetic material called microRNA (miRNA), better known for its roles in cancer, could be a key to unlocking the secrets of how HIV, the AIDS virus, evades detection, hiding in the immune system.

1 Oct 2007

Need for better flu vaccines for seniors

Each year, seasonal flu kills approximately 36,000 people in the United States, most over age 70.

25 Sep 2007

Nano device provides quick test for bird flu

A team of scientists from Singapore's Institute of Bioengineering and Nanotechnology have come up with a new test which can quickly detect the deadly H5N1 bird flu virus.

24 Sep 2007

Chronic fatigue syndrome linked to common stomach virus

A new study has provided some clues to the cause of the mystery illness called chronic fatigue syndrome (CFS).

17 Sep 2007

Loneliness can damage your health

A team of researchers at the University of California at Los Angeles (UCLA) may have found a genetic reason why lonely people have poorer health.

14 Sep 2007

Genetic link to loneliness

It's already known that a person's social environment can affect their health, with those who are socially isolated - that is, lonely suffering from higher mortality than people who are not.

13 Sep 2007

Innovative liquid crystal technology offers promise of new drugs

A partnership between Kent State University, Summa Health System and IC-MedTech Inc. has yielded an innovative liquid crystal technology that offers the promise of new drugs which may more effectively manage cancer and other diseases.

10 Sep 2007

Ardea Biosciences completes phase 1 trials of HIV drug RDEA806

Ardea Biosciences, Inc. has announced that it has successfully completed Phase 1 single-ascending-dose, multiple-ascending-dose, food-effect, and drug-interaction studies of RDEA806, a novel HIV non-nucleoside reverse transcriptase inhibitor (NNRTI), in healthy volunteers.

5 Sep 2007

Research looks at hepatitis C recovery

More than 3% of world population is infected with hepatitis C virus (HCV). The outcome of HCV infections is either self recovery or chronic hepatitis, and many of the chronic infections will develop into liver cirrhosis or liver cancer.

30 Aug 2007

Gamma globulin effective treatment for pinkeye

Gamma globulin, a type of antibody isolated from blood samples that used to be routinely given to health care workers and international travelers to protect them from infectious diseases, is a highly effective treatment for pinkeye with little apparent toxicity, according to a study by researchers at the University of Pittsburgh School of Medicine.

29 Aug 2007

Limited human-to-human spread of Avian-flu virus in Indonesia in 2006 confirmed

In the first systematic, statistical analysis of its kind, infectious-disease-modeling experts at Fred Hutchinson Cancer Research Center confirm that the avian influenza A (H5N1) virus in 2006 spread between a small number of people within a family in Indonesia.

28 Aug 2007

Roche and WHO reinforce Tamiflu as primary H5N1 treatment

The World Health Organization (WHO) has reinforced that Tamiflu (oseltamivir) is the primary recommended antiviral of choice in managing patients infected with H5N1 in updated guidance published on the WHO website today.

24 Aug 2007

Good old fashioned measures may still save lives in a pandemic

Researchers in the United States have discovered that public health measures such as quarantines, school closings and bans on public gatherings greatly reduce the death toll in flu pandemics.

8 Aug 2007